Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its robust impact on glucose control, insulin sensitivity, and body weight in metabolic and diabetes research. Manufactured under stringent...
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its robust impact on glucose control, insulin sensitivity, and body weight in metabolic and diabetes research. Manufactured under stringent quality control standards to ensure consistency and integrity in research applications.
Notice: This product is intended strictly for research purposes. It is not for human consumption or use in diagnostic, therapeutic, or clinical procedures.
